Recently, concerns have been raised by Clinical Safety Officers (CSOs) regarding the potential risks to patient safety due to NHS trusts' historical non-compliance with digital clinical safety standards. A BBC investigation revealed that 126 cases of serious harm, including three fatalities, were
In an optimistic outlook at the 43rd JPM Conference in San Francisco, Thermo Fisher CEO Marc Casper underscored the firm's strategic adaptations and growth initiatives tailored to meet surging demand for GLP-1 diabetes and weight loss products. Thermo Fisher Scientific's extensive investment in its
With the rapid advancement of technology, laboratories are increasingly seeking innovative solutions to improve their efficiency and precision, thereby reducing errors and streamlining workflows. At the SLAS 2025 International Conference & Exhibition in San Diego, ABB Robotics is preparing to
Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS
The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains
A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco
Imagine a world where obesity is not just a physical health challenge but a severe risk factor for life-threatening diseases. The increasing prevalence of obesity in modern society has become a significant concern for public health experts, especially with the stark rise in cancer cases. Delving
The integration of CRISPR technology with biomaterials engineering offers a promising avenue for safer and more effective gene therapies. Tomas Gonzalez-Fernandez, an assistant professor at Lehigh University, has received funding from the National Science Foundation’s Faculty Early Career
In a groundbreaking study, researchers have introduced a non-invasive method to predict stroke risk using a 'vascular fingerprint' identified in the retina, suggesting revolutionary potential for medical diagnostics. The method is detailed in the journal Heart, demonstrating that retinal markers
Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and
